Jefferies Cuts Price Target on Akorn (AKRX) to $24; Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Deutsche Bank Upgrades Akorn (AKRX) to Buy; Sell-Off Overdone, Says Analyst
November 7, 2016 1:46 PM ESTDeutsche Bank upgraded Akorn (NASDAQ: AKRX) from Hold to Buy with a price target of $28. Analyst Gregg Gilbert said its sell-off was overdone.
"AKRX shares are down 20% since 11/3, when the company reported 3Q results and news emerged about a DOJ investigation into suspected price collusion involving generic companies that could... More
RBC Capital Downgrades Akorn (AKRX) to Sector Perform
November 4, 2016 6:13 AM EDTRBC Capital downgraded Akorn (NASDAQ: AKRX) from Outperform to Sector Perform with a price target of $24.00 (from $37.00) on a higher risk profile and challenged P&L visibility.
Analyst Randall Stanicky commented, "As previewed on Monday, we entered 3Q looking for better clarity around FDA... More
Akorn (AKRX) Tops Q3 EPS by 2c
November 3, 2016 7:07 AM EDTAkorn (NASDAQ: AKRX) reported Q3 EPS of $0.56, $0.02 better than the analyst estimate of $0.54. Revenue for the quarter came in at $284 million versus the consensus estimate of $267.04 million.
For earnings history and earnings-related data on Akorn (AKRX) click here.
... More
